DIA 2021 Global Annual Meeting
June 27 – July 1, 2021 | Virtual
Recognizing and adapting to a new era of global change and uncertainty, DIA’s key tenets remain unchanged.
Patients are our story, we seek to understand, collaboration is the skill we hone—and this collaboration must cross organizations, decades, languages, and boundaries to have true global impact.
The DIA 2021 Global Annual Meeting pushes beyond walls and borders. It is collaboration without boundaries, and we want you to join us and play a key role in building the framework of the future—making connections, gaining skills and insights, and advancing science to improve global health.
Join Avoca for the following session:
Tuesday, June 29 | 10:00am – 11:00am
Post COVID: Sites Evolving Role in the Clinical Trial Ecosystem
Following COVID-19, there is a changing role for Sites in the decision-making framework for the selection, implementation, and use of various technologies for clinical trial execution. We will discuss how Sponsors, CROs and Sites can move forward.
Review the rapid response working group findings as it related to site execution and monitoring during the COVID-pandemic; Discuss how COVID-19 impacted traditional clinical trial execution decision making from dictating to sites how to conduct the research, to including/listening to sites for appropriate next steps; Identify how technology adoption in clinical trial execution will be decided upon.
- Cristin MacDonald, PhD, Vice President, Client Delivery, The Avoca Group
- Greg Tuyteleers, Global Operations Head Managed Access and Global Lead Decentralized Trials, Janssen
- Liz Rogers, MSc, Vice President, Head of Global Site and Study Operations, Pfizer